The continuous challenge of Chagas disease treatment: bridging evidence-based guidelines, access to healthcare, and human rights

摘要

The high morbidity and mortality burden of Chagas disease is unquestionable, both in endemic and non-endemic settings 1,2 . The globalization of the disease is increasingly recognized and has thereby broadened the debate on the right to health, demanding an integrated response between countries 1-3 . Despite its relevance as a public health problem, great failures persist in national health systems in providing access to diagnosis and treatment for affected people 3-6.